Binimetinib recalls

The FDA has published 1 recall involving Binimetinib since 2023. The latest was reported on 19 Apr 2023. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls1since 2023

Last 12 months0reported

Class I00% of total

Ongoing1latest 19 Apr 2023

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 0 0May 0 0 0Aug 0 0 0Nov 0 0 0Feb 0 0 0May 0 0 0Aug 0 0

Severity split

Class I 0 0%Class II 0 0%Class III 1 100%

Why binimetinib is recalled

Other Reasons1100%

Companies

Pfizer1100%

By year

20231100%

Ongoing binimetinib recalls

1 active

Reported	Class	Recall	Company	Reason	Where
19 Apr 2023Drug	CLASS III	Mektovi (binimetinib) tablets, 15 mg recalled by PfizerMektovi	Pfizer	Other	Nationwide

All binimetinib recalls, newest first

1 total

Reported	Class	Recall	Company	Reason	Where
19 Apr 2023Drug	CLASS III	Mektovi (binimetinib) tablets, 15 mg recalled by PfizerMektovi	Pfizer	Other	Nationwide

Should you stop taking Binimetinib?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.